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Chronic Lymphocytic Leukemia
Karyotype complexity and VH gene status in
B-cell chronic lymphocytic leukemia
B-cell chronic lymphocytic leukemia-related
genomic changes were analyzed by karyotyping,
fluorescence in situ hybridization, and VH gene
sequencing in a prospective clinical evaluation.
The VH mutational status correlated with high-risk
cytogenetic aberrations while no such relation
could be demonstrated for specific VH gene usage
(V3-21 and V1-69). Complex karyotypes were highly
indicative of disease progression.   
Haematologica 2006; 91:1430-1431
(http://www.haematologica.org/journal/2006/10/1430.html)
Genomic testing recently gained a significant role in
the characterization of chronic lymphocytic leukeima
(CLL). Lack of somatic VH hypermutation was found
indicative of instable disease with relatively short sur-
vival1,2 and specific VH gene usage (V3-21 and V1-69) could be
related with disease aggressiveness.3-5 At the chromoso-
mal level, deletions of p53 and ATM locus are the
strongest predictors of poor outcome, while normal kary-
otype or isolated deletion of 13q14 locus is an indicator
of long, symptom-free survival.6,7 The role of additional
aberrations and complex karyotypes in this system of
novel high-risk prognostic markers has not been evaluat-
ed in detail, although their total frequency seems to be
significant. Following the genomic analysis of 103 periph-
eral blood samples from CLL patients we questioned
how VH gene variables are related with individual or com-
plex chromosomal changes. 
In order to determine this, we evaluated results from
karyotyping, fluorescence in situ hybridization (FISH) and
VH gene data. Metaphase G-banding was performed after
culturing blood cells with the B-cell mitogen tetrade-
canoyl-phorbol-myristate-acetate (TPA, Sigma-Aldrich,
St. Louis, USA) for 72 hours. FISH analysis was done on
the same material using direct fluorochrome-conjugated
DNA probes (13q14; ATM, cen12 and p53, Vysis, Inc.,
Des Plaines, IL, USA). IgVH gene sequencing data were
obtained following the extraction of the genomic DNA
and multiplex polymerase chain reaction using family-
specific FR1 and consensus JH primers, as described else-
where.8
Karyotyping was successful in 76.7% of the cases
(79/103) and FISH could be interpreted in 91.3%
(94/103). Recurrent chromosome changes were observed
at similar frequencies as reported previously (50-75%)
and the correlation between high-risk aberrations and
unmutated VH status was reproduced in our series (Table
1). Among the 31 different VH genes that we identified,
the V1-69 gene (13/64, 20.31%) was the most frequent. All
were of unmutated nature showing 100% sequence
homology with one exception. Five out of the 13 cases
presented with cytogenetic aberrations, two with
del(17)(p13), two with +12 and one case with three dele-
tions including the loci 13q14, 6q22-24 and 11q22-23. 
The second most frequent gene, V3-21, was identified in
7.85% (5/64). Hypermutation was demonstrated in two
out of five cases. One of them showed a normal cytoge-
netic profile while the other displayed an isolated dele-
tion of the 13q14 locus. Of the three unmutated cases
using V3-21, one appeared to be normal by cytogenetics,
while the remaining two presented with del(13)(q14) and
additional aberrations. 
The overall frequencies of V1-69 and V3-21 gene usage
were in the ranges reported previously (15.7-22.6% and
2.9-11.2%, respectively).4,5 Neither V1-69 nor V3-21 usage
was associated with specific chromosome aberrations. 
The most frequent chromosomal aberrations were
deletions of 13q, 11q, 17p, 6q as well as trisomy 12; how-
ever, a few other abnormalities (numeric and transloca-
tions) were also demonstrated in the present series, in
part obviously accompanying the mentioned standard
aberrations. 
Two or more chromosomal aberrations were found in
16/103 cases (15.5%) which were in good association
with unmutated VH status but not with any specific VH
gene usage. Early transition to Rai stage III-IV was
observed, in conjunction with complex chromosome
aberrations, supporting the role of accumulating genetic
failures during disease progression. In six cases such clon-
al structural changes were identified which were not
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Table 1. Correlation between IgVH hypermutational status VH gene
usage and the occurrence of cytogenetic aberrations in 64 sam-
ples sequenced for the relevant variable region. 
Chromosome abnormality
IgVH n del del +12* del isolated del(13q) normal
(17p) (11q) (6q)* (del13q) combined
Mutation 
status
Mutated 31 2 1 0 1 12 1 16
Unmutated 33 4 8 4 3 2 8 8
Gene usage
V1-69 13 2 1 2 1 − 1 8
V3-21 5 1 − − − 1 2 2
non-V1-69 46 3 8 2 3 13 6 14
or V3-21
Total 64 6 9 4 4 14 9 24
V segment hypermutation was determined using a cut-off of 98% sequence
homology (*determined in part only by karyotyping).
Table 2. VH gene status and disease outcome in CLL with aberra-
tions other than del17p, del11q, del13q and +12.    
Case VH VH hyper Karyotype Outcome
usage mutation
1 V3-20 U 46, XY, t(4;11)(p15;q21), +3, +8 [8] DOD
2 V1-8 M 44, X, -Y, t(1;14)(q31;q32), DOD
add(6)(qter), -14 [22]
3 V1-69 U 46, XY, t(1;10)(q12 ;q21 ), P
del(6)(q22q26), del(11)(q21q23),
del(13)(q13q14) [4] 
4 nd nd 46, XX, der(12)t(?;12)(?;?) [3] P
5 V4-39 U 46, XY, inv(4)(p?q?), del(6)(q22q26), P
del(11)(q21q23), del(13)(q14q22)  [3] 
6 V3-21 U 46, XX, del(13)(q14q22), D
add(16)(pter) [12] 
DOD: died of disease within 30 months of observation, P: clinical progression;
D: died of other cause, S: stable disease, nd: no data; U: unmutated; M: mutated.
 
challenging our four probe FISH approach (Table 2).
Moreover, in three cases (no. 1, 2 and 4, Table 2) none of
the clonal karyotype changes was covered by FISH.
According to our clinical records two of these cases (cases
no. 1 and 2.) proved to be highly aggressive and terminat-
ed in early death within 30 months of follow-up despite
intensified treatment. Lack of VH mutation was demon-
strated in only one of them and these cases were not
characterized by specific high-risk VH usage. 
We conclude that complex karyotypes in CLL may con-
sist of combinations of standard recurrent chromosomal
changes but also of infrequent translocations and of
aneusomies. These represent progressive disease arising
on the basis of sequential genomic events. Karyotype
evolution not following the classical route in CLL seems
to be rare but highly indicative of aggressiveness; more-
over, such cases may escape proper risk assessment if
evaluated by targeted molecular methods. An extended
study should clarify whether such cytogenetic profiles
characterize a group with highly unfavorable disease and
how these changes are related to established high-risk
prognostic factors.
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